Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 2, 2004, Pages 202-207

  Kang, Won Jun ^a   Chung, June Key ^a   So, Young ^a   Jeong, Jae Min ^a   Lee, Dong Soo ^a   Lee, Myung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

FDG; Lymph nodes; Mediastinum; Neoplasm; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BIOPSY; CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; GRANULOMATOSIS; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM TUMOR; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; SMOKING; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MEDIASTINUM; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THORACIC NEOPLASMS;

EID: 0842290765     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1368-x     Document Type: Article

References (11)

1. Gambhier SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42:1S-93S.
2. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ. Preoperative staging of non-small-cell lung cancer with positronemission tomography. N Engl J Med 2000; 343:254-261.
3. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999; 213:530-536.
4. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723.
5. Yeung H, Macapinlac H, Mazumdar M, Bains M, Finn R, Larson S. FDG-PET in esophageal cancer: incremental value over computed tomography. Clin Positron Imaging 1999; 2:255-260.
6. Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW. Wholebody FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000; 25:882-887.
7. 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer Res 2001; 21:701-706.
8. Goo JM, Im J-G, Do K-H, Yeo JS, Seo JB, Kim HY, Chung J-K. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216:117-121.
9. Yamada Y, Uchida Y, Tatsumi K, Yamaguchi T, Kimura H, Kitahara H, Kuriyama T. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998; 39:1160-1166.
10. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998; 2:27-36.
11. Keyes JW Jr. SUV: standard uptake value or silly useless value? J Nucl Med 1995; 36:1836-1839.